🔗 Share this article

A shadow economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.

Experimental Treatment Acquiring Popularity Via Social Media

The experimental drug, which remains in clinical trials, is being promoted by online personalities for its alleged fat-burning effects. Followers are encouraged to message these accounts privately for source information, while also receiving promotional offers.

Active Trade on Messaging Platforms

Separately, a robust trade exists on Telegram, where communities with numerous of participants share comparison photos, injection guides and assertions of rapid British shipping. Sellers market the drug there before redirecting buyers to WhatsApp for purchases.

Learning About The Experimental Drug

This medication is an experimental injection created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Medical Experts Voice Concerns

However, physicians and pharmacists have cautions that the sale of what is still an unlicensed drug in the United Kingdom is a cause for concern and could result in users administering products of unknown origin.

Several professionals stated the demand for the experimental drug could be linked to the increasing cost of approved weight loss treatments such as Mounjaro.

Legal Status and Implementation

Selling the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unapproved drug that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Several content creators try to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still breach medicines, advertising, and consumer laws, risking penalties, prosecution or imprisonment.

Platform Response and Content Removal

Based on TikTok, the service has removed problematic content and prohibited associated hashtags and query recommendations. The organization said it was dedicated to keeping the service secure and investing in enhancing enforcement strategies.

Digital Marketplace Operations

Investigations also found groups with up to 9,000 participants selling retatrutide using Telegram's integrated search feature, which functions like a online catalog. Entering “retatrutide” immediately displays channels with numerous of users, populated with images of weight loss, glowing reviews and step-by-step guides for mixing or injecting at residence.

Within moments of joining one community, a seller posted contact information, where the majority of purchases take place. The vendor sent an instruction manual and promised shipping within two days. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. Not one asked about weight, medical conditions or past usage.

Product Details and Costs

Within these communities, posts display black plastic parcels with Royal Mail stickers, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at home with sterile water, or ready-to-use pens usually sold at 160 pounds for 20mg. When asked how long a pen should last, sellers give contradictory answers ranging from a few weeks to “depends on your body”.

Service Oversight and Security Actions

A spokesperson for the messaging service said it actively monitored dangerous material on its service including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are injecting materials they can’t verify. Although the research behind this drug is valid, these digital products may not include what they claim,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor linked the surge in interest to recent cost increases for approved slimming drugs such as Mounjaro. “With prices increasing, patients are using social media. But counterfeit injections are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she said.

Her staff has already seen patients injured by self-injection from unconfirmed suppliers. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” stated the doctor. “These substances could be contaminated or improperly measured.”

Manufacturer Position

A representative from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a company experimental substance not yet authorized … may expose users to potentially significant medical dangers”.